Dr Arno Hazekamp
Independent Consultant for Cannabis Research, Development and Education
About this event
- Date and time Mon 11 Oct 2021 from 9:00am to 5:30pm
- Location Online
- Organised by Pain Medicine, Integro Medical Clinics Limited
This comprehensive one-day online course will delve into the safe practice of cannabis medicines. Join us to explore the history, regulatory environment, and pharmacology of cannabis medicines as well as the use of different cannabis-based medical preparations for future use in a wide variety of clinical fields in the UK.
Do you want to attend this meeting in Central London? Click here to book your place.
This course will be of interest to pain specialists and all other clinicians who are interested in pain management, pharmacology and regulatory background of cannabis medicines for long term pain and associated symptoms.
During this session, participants will be able to:
- Know the pharmacology of cannabis medicines
- Understand the regulatory framework within which cannabis medicines can be used safely in medical practice
- Understand the practicalities of cannabis medicine and how cannabis medicines can be best used in clinical practice
- Take a look at the future of cannabis medicine in the UK through research and how the development of cannabis-based treatments may be of benefit in other clinical fields
This live stream is available for on-demand viewing. The recording will be available for registered delegates up to 60 days after the live broadcast via Zoom. The link will be sent 24 hours after the live stream takes place.
The importance of representation (for example, gender and ethnicity) in medicine, particularly in medical cannabis, is something that The Royal Society of Medicine and Integro Medical Clinics Limited take seriously. Gender balance is something that was considered whilst designing the programme, however, we understand that due to the previous illegality and controversy surrounding medical cannabis, its acceptance into mainstream clinical practice is currently limited. We hope to help in changing this through educational events such as this one. Therefore, we are pleased to have some of the most influential and knowledgeable clinicians and researchers in the field of medical cannabis present at this meeting. Through events such as this, the hope is that more diverse professionals, especially women, within medicine and research feel more confident in exploring the potential that can be found in this field.
This meeting is in association with Eurox and Integro Medical Clinics who have provided funding support as well as input into the meeting agenda.
We would also like to thank our sponsors Aurora Medicine UK Limited, Grow Pharma, LVL Health and The Centre for Medicinal Cannabis for their support of this meeting. Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of the meetings.
Join in the conversation online
Follow us on Twitter: @RoySocMed
Key speakers
Dr Matthew Brown
Consultant in Pain Medicine, Anaesthetics and Medical Cannabis, Royal Marsden and the Institute of Cancer Research
Dr Paul Chrisp
Director of the Centre for Guidelines, NICE
Professor Raphael Mechoulam
Professor of Medicinal Chemistry, Hebrew University of Jerusalem, Israel
Agenda
View the programme
Welcome and introduction
Dr Anthony Ordman, Consultant in Pain Medicine
Session one
Chair: Dr Anthony Ordman
History of cannabis medicines and process to legalisation on prescription in UK (Epilepsy in children)
Alex Fraser, Patient Access Lead, GrowPharma
Pharmacology of cannabis medicines
Professor Raphael Mechoulam, Professor of Medicinal Chemistry, Hebrew University of Jerusalem, Israel
The development of cannabis medicines in the UK and Europe
Dr Arno Hazekamp, Independent Consultant for Cannabis Research, Development and Education
Growing and production of cannabis medicines in UK and Europe
Mike Kindrat, CEO, Eurox Group
Panel discussion
Professor Raphael Mechoulam, Dr Arno Hazekamp and Ian Atkinson, CSO, Grow Biotech
Coffee break
Session two
Chair: Dr Basil Almahdi
Cannabis medicines and UK regulation in pain medicine
Dr Paul Chrisp, Director of the Centre for Guidelines, NICE
Setting up a cannabis medicine clinic in the UK regulatory environment and the patient journey
Dr Anthony Ordman, Consultant in Pain Medicine
Education and support for clinicians
Dr Ayesha Mian, Board of Advisors of The Centre for Medicinal Cannabis UK
Panel discussion
Dr Paul Chrisp, Dr Anthony Ordman, Dr Ayesha Mian and Alex Fraser
Lunch
Session three
Chair: Alex Fraser
Vapes, oils, capsules and patches and comparisons with current chronic pain treatment options, Fibromyalgia and Ehlers Danlos
Dr Anthony Ordman, Consultant in Pain Medicine
Cannabis medicines in practice
Sophie Hayes, Specialist Nurse, Integro Clinics and Clinical Lead of CPASS Nurses Arm
Cannabis medicines and migraine
Dr Basil Almahdi, Consultant in Pain Medicine
Women’s health
Dr Sally Ghazaleh, Consultant in Pain Medicine and Mr Srinivas Vindla
Psychiatry
Dr Mayur Bodani, Consultant Neuropsychiatrist
Oncology
Dr Andrew Gaya, Consultant Oncologist
Panel discussion
Dr Andrew Gaya, Dr Basil Almahdi, Dr Mayur Bodani and Sophie Hayes
Coffee break
Session four
Chair: Dr Mayur Bodani
Current clinical research cannabis medicines UK
Dr Matt Brown, Consultant in Pain Medicine, Anaesthetics and Medical Cannabis, Royal Marsden and the Institute of Cancer Research
Real world data and the future of cannabis medicine research in the UK
Mr John Brew, Pharmacologist and Regulatory authority, LVL Health
Panel discussion
Dr Matt Brown and Mr John Brew
Closing remarks and end of meeting
Dr Anthony Ordman, Consultant in Pain Medicine
Sponsors
Location
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
